Mereo BioPharma (MREO) Current Taxes (2021)

Mereo BioPharma (MREO) posted quarterly Current Taxes of $2.1 million for Q4 2021.

Mereo BioPharma (MREO) Current Taxes (2021) Analysis & Trends

Mereo BioPharma (MREO) has reported Current Taxes for 1 consecutive years, with $2.1 million the latest figure, recorded in Q4 2021.

  • Quarterly Current Taxes changed N/A year-over-year to $2.1 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $2.1 million (changed N/A YoY) and the FY2021 annual result came in at $2.1 million, changed N/A from the prior year.
  • Current Taxes held at $2.1 million in Q4 2021 per MREO's latest filing.
  • Over the last five years, Current Taxes for MREO reached as high as $2.1 million in Q4 2021 and fell as low as $2.1 million in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 63.52 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 49.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Mereo BioPharma 232.52 Mn 232.52 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2021 2.05 Mn